Dihydrostreptomycin Sulfate USP from Japan
Dihydrostreptomycin sulfate is the sulfate salt of dihydrostreptomycin, a semi-synthetic aminoglycoside antibiotic derived from streptomycin. It is chemically defined as a separate organic compound and falls under HTS 2941.20.10.00 as a dihydrostreptomycin derivative salt used primarily in veterinary and human antibiotic formulations.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6211.5%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Provide Certificate of Analysis (CoA) confirming USP grade purity and identity as dihydrostreptomycin sulfate to avoid reclassification
• Ensure FDA prior notice and drug import documentation; veterinary vs human use affects labeling requirements
• Verify absence of impurities exceeding pharmacopeia limits to maintain classification under Chapter 29 antibiotics